Stifel Financial Corp Care Dx, Inc. Transaction History

Stifel Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $286,737 - $555,841	-13,994 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$28.19 - $46.6 $4,425 - $7,316	157 Added 1.13%	13,994 $518,000
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $10,011 - $17,884	243 Added 1.79%	13,837 $629,000
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $29,160 - $45,351	-493 Reduced 3.5%	13,594 $861,000
Q2 2021 Aug 13, 2021	SELL	$63.02 - $95.11 $4,411 - $6,657	-70 Reduced 0.49%	14,087 $1.29 Million
Q1 2021 May 14, 2021	SELL	$57.62 - $95.6 $236,645 - $392,629	-4,107 Reduced 22.49%	14,157 $964,000
Q4 2020 Feb 12, 2021	BUY	$41.43 - $77.09 $35,505 - $66,066	857 Added 4.92%	18,264 $1.32 Million
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $108,203 - $132,941	-3,504 Reduced 16.76%	17,407 $661,000
Q2 2020 Aug 14, 2020	BUY	$18.95 - $35.43 $38,714 - $72,383	2,043 Added 10.83%	20,911 $741,000
Q1 2020 May 14, 2020	BUY	$13.94 - $28.25 $263,019 - $533,021	18,868 New	18,868 $448,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.13B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.